Skip to search formSkip to main contentSkip to account menu

SLC26A8 gene

Known as: solute carrier family 26 member 8, TESTIS ANION TRANSPORTER 1, SLC26A8 
National Institutes of Health

Related topics

Related topics

1 relation
SLC16A10 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Role of T-Type Amino Acid Transporter TAT 1 ( S 1 C 16 a 10 ) in Aromatic Amino Acid Homeostasis
TAT1 (T-type amino acid transporter 1), also known as SLC16A10 (solute carrier family 16, member 10), aromatic amino acid… 
2014
2014
Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors.
2012
2012
News from the dark side!
The fundamental importance of any given membrane transport protein is something that is stated repeatedly at conferences with… 
2012
2012
Transfer of the ability of HIV-1 Tat to raise an adjuvant-free humoral immune response to unrelated antigens.
2012
2012
Carcinoma in situ of urinary bladder: incidence, treatment and clinical outcomes during ten-year follow-up.
Bladder carcinoma in situ (CIS) is a rare, high-grade intraepithelial neoplasm with a high tendency of progression and… 
2011
2011
Investigator in training
HIV infection continues to rise in drug abusing populations. However the combined effect of HIV and drugs of abuse have not been… 
2011
2011
Regulation and Dynamics of Tryptophan Import in Yeast Analyzed Using High Hydrostatic Pressure
High hydrostatic pressure has an adverse influence in organisms that inhabit atmospheric pressure environments. In yeast… 
2006
2006
Association of PAX5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder.
2003
2003
Using capillary electrophoresis to study methylation effect on RNA-peptide interaction.
Methylation of RNA and proteins is one of a broad spectrum of post-transcriptional/translational mechanisms of gene expression… 
1991
1991
Tumour-associated trypsin inhibitor and CA-125 during treatment of mucinous ovarian cancer in 2 patients
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)